U.S IVF Services Market by Cycle Type (Fresh IVF Cycle, Thawed IVF Cycle and Donor egg IVF cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Analysis and Industry Forecast, 2019–2027
The U.S. IVF market was valued at $4,905.46 million in 2020, and is expected to reach $5,563.06 million by 2027, registering a CAGR of 6.8% from 2019 to 2027.
IVF is a complex series of procedure used to help by fertility or avoid genetic problems and assist with the conception of a child. Throughout IVF, mature eggs are collected from ovaries and fertilized by sperm in a lab The U.S. IVF market experiences growth, owing to rise in number of infertility cases, availability of skilled professionals, and technological advancements including preimplantation genetic diagnosis (PGD) and three-parent IVF procedures.
Delayed pregnancies; aging of women population, which lowers conception rates; and introduction of new & advanced products of IVF treatments enhance the market growth. IVF procedures are associated with high success rate, thus fueling the market growth. For instance, according to the Society for Assisted Reproductive Technology (SART), in 2016 around 1.8% babies born in the U.S were conceived through IVF procedures. However, factors such as high cost of IVF treatment and stringent government regulations are expected to affect the market growth. For example, one IVF cycle costs around $12,000 to $15,000 excluding cost of medicines.
Increase in developments in fertility clinics and novel IVF technologies are expected to offer lucrative growth opportunities for IVF service providers in the future. Moreover, rise in number of multiple pregnancy problem cases in the U.S. increase the employment of IVF procedures, which is expected to propel the market growth in the near future
The U.S IVF services market is segmented on the basis of cycle type and end user. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the market is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
The U.S IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
KEY BENEFITS FOR STAKEHOLDERS
By Cycle Type
IVF is a complex series of procedure used to help by fertility or avoid genetic problems and assist with the conception of a child. Throughout IVF, mature eggs are collected from ovaries and fertilized by sperm in a lab The U.S. IVF market experiences growth, owing to rise in number of infertility cases, availability of skilled professionals, and technological advancements including preimplantation genetic diagnosis (PGD) and three-parent IVF procedures.
Delayed pregnancies; aging of women population, which lowers conception rates; and introduction of new & advanced products of IVF treatments enhance the market growth. IVF procedures are associated with high success rate, thus fueling the market growth. For instance, according to the Society for Assisted Reproductive Technology (SART), in 2016 around 1.8% babies born in the U.S were conceived through IVF procedures. However, factors such as high cost of IVF treatment and stringent government regulations are expected to affect the market growth. For example, one IVF cycle costs around $12,000 to $15,000 excluding cost of medicines.
Increase in developments in fertility clinics and novel IVF technologies are expected to offer lucrative growth opportunities for IVF service providers in the future. Moreover, rise in number of multiple pregnancy problem cases in the U.S. increase the employment of IVF procedures, which is expected to propel the market growth in the near future
The U.S IVF services market is segmented on the basis of cycle type and end user. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. According to end user, the market is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
The U.S IVF services market is segmented on the basis of cycle type, end user, and country. By cycle type, it is divided into fresh IVF cycle (non-donor), thawed IVF cycle (non-donor), and donor egg IVF cycle. On the basis of end user, it is classified as fertility clinics, hospitals, surgical centers, and clinical research institutes.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the U.S IVF services market.
- In depth quantitative analysis of the current market trends and estimations from 2019 to 2027.
- The IVF services market is analyzed on the basis of cycle type and end user.
- Extensive analysis of the market is conducted by monitoring top competitors within the market framework.
- Key players are profiled to understand the competitive outlook of the U.S market.
By Cycle Type
- Fresh IVF Cycles (Non-Donor)
- Thawed IVF Cycles (Non-Donor)
- Donor Egg IVF Cycles
- Fertility Clinics
- Hospitals
- Surgical centers
- Clinical research institutes
- Boston IVF
- Conceptions Reproductive Associates
- Cardone Reproductive Medicine & Infertility
- Fertility Center of San Antonio
- Fertility and Gynecology Center Monterey Bay IVF
- Houston Fertility Center
- New hope fertility center
- Reproductive Medicine Associates of New Jersey
- Servy Massey Fertility Institute
- Sher Institute for Reproductive Medicine (SIRM)
CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Overview
3.2.1.Market Size and forecast
3.2.2.Number of infertility clinics, 2016
3.2.3.Regulatory issues, legislations, and authorities
3.2.4.Insurance reimbursement scenario
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Delayed Pregnancies in Women
3.3.1.2.Rise in popularity of IVF in the U.S.
3.3.1.3.Growth in rate of infertility and practices of embryo banking cycles
3.3.1.4.Technological advancements in IVF treatment
3.3.2.Restraints
3.3.2.1.High cost of IVF treatments in the U.S
3.3.2.2.Restrictions on three-parent IVF treatments
3.3.2.3.Scattered Reimbursements
3.3.3.Opportunities
3.3.3.1.Rise in Inter-Sex Marriage
3.3.4.Impact analyses
3.3.5.COVID-19 Impact Analysis for IVF Market.
CHAPTER 4: U.S IVF SERVICES MARKET, BY END USER
4.1.Overview
4.1.1.Market size and forecast
4.1.2.Market size and forecast
4.1.3.Fertility clinics
4.1.3.1.Market Size and Forecast
4.1.4.Hospitals
4.1.4.1.Market Size and Forecast
4.1.5.Surgical centers
4.1.5.1.Market Size and Forecast
4.1.6.Clinical research institutes
4.1.6.1.Market Size and Forecast
CHAPTER 5: U.S IVF SERVICES MARKET, BY CYCLE TYPE
5.1.Overview
5.1.1.Market size and forecast
5.1.2.Market volume and forecast
5.1.3.Fresh IVF cycles (non-donor)
5.1.3.1.Market Size and Forecast
5.1.4.Thawed IVF cycles (non-donor)
5.1.4.1.Market Size and Forecast
5.1.5.Donor egg IVF cycles
5.1.5.1.Market Size and Forecast
CHAPTER 6: COMPANY PROFILES
6.1.BOSTON IVF
6.1.1.Company overview
6.2.CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
6.2.1.Company overview
6.3.CONCEPTIONS REPRODUCTIVE ASSOCIATES OF COLORADO
6.3.1.Company overview
6.4.FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF
6.4.1.Company overview
6.5.FERTILITY CENTER OF SAN ANTONI
6.5.1.Company overview
6.6.HOUSTON FERTILITY CENTER
6.6.1.Company overview
6.7.NEW HOPE FERTILITY CENTER
6.7.1.Company overview
6.8.SERVY MASSEY FERTILITY INSTITUTE
6.8.1.Company overview
6.9.REPRODUCTIVE MEDICINE ASSOCIATES
6.9.1.Company overview
6.10.SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
6.10.1.Company overview
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Overview
3.2.1.Market Size and forecast
3.2.2.Number of infertility clinics, 2016
3.2.3.Regulatory issues, legislations, and authorities
3.2.4.Insurance reimbursement scenario
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Delayed Pregnancies in Women
3.3.1.2.Rise in popularity of IVF in the U.S.
3.3.1.3.Growth in rate of infertility and practices of embryo banking cycles
3.3.1.4.Technological advancements in IVF treatment
3.3.2.Restraints
3.3.2.1.High cost of IVF treatments in the U.S
3.3.2.2.Restrictions on three-parent IVF treatments
3.3.2.3.Scattered Reimbursements
3.3.3.Opportunities
3.3.3.1.Rise in Inter-Sex Marriage
3.3.4.Impact analyses
3.3.5.COVID-19 Impact Analysis for IVF Market.
CHAPTER 4: U.S IVF SERVICES MARKET, BY END USER
4.1.Overview
4.1.1.Market size and forecast
4.1.2.Market size and forecast
4.1.3.Fertility clinics
4.1.3.1.Market Size and Forecast
4.1.4.Hospitals
4.1.4.1.Market Size and Forecast
4.1.5.Surgical centers
4.1.5.1.Market Size and Forecast
4.1.6.Clinical research institutes
4.1.6.1.Market Size and Forecast
CHAPTER 5: U.S IVF SERVICES MARKET, BY CYCLE TYPE
5.1.Overview
5.1.1.Market size and forecast
5.1.2.Market volume and forecast
5.1.3.Fresh IVF cycles (non-donor)
5.1.3.1.Market Size and Forecast
5.1.4.Thawed IVF cycles (non-donor)
5.1.4.1.Market Size and Forecast
5.1.5.Donor egg IVF cycles
5.1.5.1.Market Size and Forecast
CHAPTER 6: COMPANY PROFILES
6.1.BOSTON IVF
6.1.1.Company overview
6.2.CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
6.2.1.Company overview
6.3.CONCEPTIONS REPRODUCTIVE ASSOCIATES OF COLORADO
6.3.1.Company overview
6.4.FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF
6.4.1.Company overview
6.5.FERTILITY CENTER OF SAN ANTONI
6.5.1.Company overview
6.6.HOUSTON FERTILITY CENTER
6.6.1.Company overview
6.7.NEW HOPE FERTILITY CENTER
6.7.1.Company overview
6.8.SERVY MASSEY FERTILITY INSTITUTE
6.8.1.Company overview
6.9.REPRODUCTIVE MEDICINE ASSOCIATES
6.9.1.Company overview
6.10.SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
6.10.1.Company overview
LIST OF TABLES
TABLE 01.U.S IVF MARKET, VOLUME AND VALUE, 2019-2027 (THOUSAND AND $ MILLION)
TABLE 02.NUMBER OF FERTILITY CLINICS IN U.S (2016)
TABLE 03.ART REGULATORY SCENARIO, U.S
TABLE 04.U.S IVF SERVICES MARKET, BY END USER, 2019–2027 (THOUSAND)
TABLE 05.U.S IVF SERVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 06.U.S IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2019–2027 ($MILLION)
TABLE 07.U.S IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2019–2027 (THOUSAND)
TABLE 08.BOSTON IVF BUSINESS OVERVIEW
TABLE 09.SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
TABLE 10.CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC BUSINESS OVERVIEW
TABLE 11.SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
TABLE 12.CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
TABLE 13.SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATES
TABLE 14.FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
TABLE 15.SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY
TABLE 16.FERTILITY CENTER OF SAN ANTONI BUSINESS OVERVIEW
TABLE 17.SNAPSHOT OF FERTILITY CENTER OF SAN ANTONI
TABLE 18.HOUSTON FERTILITY CENTER BUSINESS OVERVIEW
TABLE 19.NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
TABLE 20.SNAPSHOT OF NEW HOPE FERTILITY CENTER
TABLE 21.SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 22.SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
TABLE 23.REPRODUCTIVE MEDICINE ASSOCIATES BUSINESS OVERVIEW
TABLE 24.SNAPSHOT OF REPRODUCTIVE MEDICINE ASSOCIATES
TABLE 25.SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM) BUSINESS OVERVIEW
TABLE 26.SNAPSHOT OF SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
TABLE 01.U.S IVF MARKET, VOLUME AND VALUE, 2019-2027 (THOUSAND AND $ MILLION)
TABLE 02.NUMBER OF FERTILITY CLINICS IN U.S (2016)
TABLE 03.ART REGULATORY SCENARIO, U.S
TABLE 04.U.S IVF SERVICES MARKET, BY END USER, 2019–2027 (THOUSAND)
TABLE 05.U.S IVF SERVICES MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 06.U.S IVF SERVICES MARKET REVENUE, BY CYCLE TYPE, 2019–2027 ($MILLION)
TABLE 07.U.S IVF SERVICES MARKET VOLUME, BY CYCLE TYPE, 2019–2027 (THOUSAND)
TABLE 08.BOSTON IVF BUSINESS OVERVIEW
TABLE 09.SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
TABLE 10.CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC BUSINESS OVERVIEW
TABLE 11.SNAPSHOT OF CARDONE REPRODUCTIVE MEDICINE AND INFERTILITY, LLC
TABLE 12.CONCEPTIONS REPRODUCTIVE ASSOCIATES BUSINESS OVERVIEW
TABLE 13.SNAPSHOT OF CONCEPTIONS REPRODUCTIVE ASSOCIATES
TABLE 14.FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY IVF BUSINESS OVERVIEW
TABLE 15.SNAPSHOT OF FERTILITY AND GYNECOLOGY CENTER MONTEREY BAY
TABLE 16.FERTILITY CENTER OF SAN ANTONI BUSINESS OVERVIEW
TABLE 17.SNAPSHOT OF FERTILITY CENTER OF SAN ANTONI
TABLE 18.HOUSTON FERTILITY CENTER BUSINESS OVERVIEW
TABLE 19.NEW HOPE FERTILITY CENTER BUSINESS OVERVIEW
TABLE 20.SNAPSHOT OF NEW HOPE FERTILITY CENTER
TABLE 21.SERVY MASSEY FERTILITY INSTITUTE BUSINESS OVERVIEW
TABLE 22.SNAPSHOT OF SERVY MASSEY FERTILITY INSTITUTE
TABLE 23.REPRODUCTIVE MEDICINE ASSOCIATES BUSINESS OVERVIEW
TABLE 24.SNAPSHOT OF REPRODUCTIVE MEDICINE ASSOCIATES
TABLE 25.SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM) BUSINESS OVERVIEW
TABLE 26.SNAPSHOT OF SHER INSTITUTE FOR REPRODUCTIVE MEDICINE (SIRM)
LIST OF FIGURES
FIGURE 01.IVF SERVICES MARKET SEGMENTATION
FIGURE 02.IMPACT ANALYSES, IVF SERVICES MARKET
FIGURE 03.U.S IVF SERVIVES MARKET FOR FERTILITY CLINICS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 04.U.S IVF SERVICES MARKET FOR BY HOSPITALS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 05.U.S IVF SERVICES MARKET FOR SURGICAL CENTERS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 06.U.S IVF SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 07.U.S IVF SERVICES MARKET FOR FRESH IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 08.U.S IVF SERVICES MARKET FOR THAWED IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 09.U.S IVF SERVICES MARKET FOR DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
COMPANIES MENTIONED
Boston IVF, Fertility and Gynecology Center Monterey Bay IVF, Conceptions Reproductive Associates, Servy Massey Fertility Institute, Sher Institute for Reproductive Medicine (SIRM), Cardone Reproductive Medicine & Infertility, Fertility Center of San Antonio, Houston Fertility Center, New hope fertility center, and Reproductive Medicine Associates of New Jersey.
FIGURE 01.IVF SERVICES MARKET SEGMENTATION
FIGURE 02.IMPACT ANALYSES, IVF SERVICES MARKET
FIGURE 03.U.S IVF SERVIVES MARKET FOR FERTILITY CLINICS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 04.U.S IVF SERVICES MARKET FOR BY HOSPITALS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 05.U.S IVF SERVICES MARKET FOR SURGICAL CENTERS, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 06.U.S IVF SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 07.U.S IVF SERVICES MARKET FOR FRESH IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 08.U.S IVF SERVICES MARKET FOR THAWED IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
FIGURE 09.U.S IVF SERVICES MARKET FOR DONOR EGG IVF CYCLES, VOLUME AND VALUE, 2019-2027, (THOUSAND, $MILLION)
COMPANIES MENTIONED
Boston IVF, Fertility and Gynecology Center Monterey Bay IVF, Conceptions Reproductive Associates, Servy Massey Fertility Institute, Sher Institute for Reproductive Medicine (SIRM), Cardone Reproductive Medicine & Infertility, Fertility Center of San Antonio, Houston Fertility Center, New hope fertility center, and Reproductive Medicine Associates of New Jersey.
